Of their many claims in court documents, plaintiffs say Eli Lilly: Overstated the efficacy of Cymbalta and downplayed and/or failed to state the true withdrawal side effects associated with Cymbalta Failed to properly warn patients about the risks and of the frequency, severity, and/or duration of Cymbalta withdrawal Benefitted from patients who started taking Cymbalta again (becoming physically dependent on the drug) to avoid terrible side effects Advertised the benefits of the drug, even those that were not proven Produced a defective drug The lawsuits also say Eli Lilly deceived the public by including in the drugs label that only 1% of users experienced withdrawal symptoms, when in reality studies show between 44% and 50% suffered from discontinuation problems
J Accid Emerg Med
Le personnel mdical tait vraiment gentil et serviable et m'a fourni le type de mdicament que je voulais, donc je n'ai que de bonnes choses dire
Does Semaglutide Cause Pancreatitis
They usually follow Medicare policies, so, generally, no, GLP-1s are not covered for weight loss
Patients should be aware of important safety considerations, including risks of pancreatitis, gallbladder disease, and potential worsening of diabetic retinopathy in those with pre-existing disease